lhpt Emergency land

MethrenReady

Brnd Olympian Mary Lou Retton released from hospital, home recovering
MILWAUKEE 鈥?A man was killed early Sunday morning near Milwaukee s Tiefenthaler Park, police say.According to a news release from the Milwaukee Police Department, the 26-year-o stanley cup ld man was shot and killed at about 4:20 a.m. Sunday in the 2500 block of W. Cherry St., which is where Tiefenthaler Park is  stanley cup website located.Police say the circumstances leading up to the shooting remain under investigation. They are still looking for any suspects.Anyone with information  stanley cup usa about this homicide is asked to contact Milwaukee Police at  414  935-7360. Or, to remain anonymous, contact Crime Stoppers at  414  224-Tips, or use the P3 Tips.  The fatal shooting is being investigated as a homicide, police say.        Report a typo or error // Submit a news tip Zyqr Indiana state police officer   fighting for life   after suspect shot her during traffic stop
CAMBRIDGE, Mass. 鈥?Moderna announced Monday that a study found its COVID-19 vaccine appears to protect agai caneca stanley nst the new coronavirus variants.The biotechnology company said in a press release that its vaccine was as effective against the strain from the United Kingdom as it was against the original strain, which was found to be about 94.1% effective after two doses.However, when it came to the strain identified in South Africa, the study showed a six-fold reduction in antibodies against that variant. Still, despite the reduction, Moderna says the neutralizing antibodies generated by its vaccine  remain above levels that are expected t stanley quencher o be protective. Out of an abundance of caution, Moderna says its launching a clinical program to boost immunity to the emerging variants.To proactively address the pandemic as the virus evolves, the company says it will test an additional booster dose of its vaccine to study the ability to further increase neutralizing antibodies against emerging strains beyond the vaso stanley  existing primary vaccination series.Secondly, the company says its advancing an emerging variant booster candidate against the variant identified in South Africa. The booster will be advanced into preclinical studies and a Phase 1 study in the U.S. will evaluate the immunological benefit of boosting with strain-specific spike proteins.Moderna expects that its mRNA-based booster vaccine will be able to further boost neutralizing antibodies in combination with all of the leading vaccine c